T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody

Anticancer Research

Volumn 22, Issue 2 A, 2002, Pages 769-776

  Ueno, Aruto ^a   Arakawa, Fumiko ^a   Abe, Hironori ^a   Matsumoto, Hisanobu ^a   Kudo, Toshio ^a   Asano, Ryutaro ^a   Tsumoto, Kohei ^a   Kumagai, Izumi ^a   Kuroki, Motomu ^a   Kuroki, Masahide ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fusion protein; Immunotherapy; scFv; SEA; Superantigen

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; GENE PRODUCT; GLYCOPROTEIN; HYBRID PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAPHYLOCOCCUS ENTEROTOXIN A; SUPERANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER IMMUNOTHERAPY; CYTOTOXICITY; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CYTOTOXICITY, IMMUNOLOGIC; ENTEROTOXINS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTHERAPY; IMMUNOTOXINS; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE ACTIVATION; MICE; MICE, SCID; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS; STOMACH NEOPLASMS; SUPERANTIGENS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0036244015     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. The Vb-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice
2. Superantigen mediated shock: A cytokine release syndrome
3. T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant
4. Genetically engineered superantigens as tolerable antitumor agents
5. A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma
6. Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1
7. Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2
8. Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies
9. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies
10. Initial clinical evaluation of two murine IgG2a monoclonal antibodies for immunotherapy of gastrointestinal carcinoma
11. Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response
12. Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patients
13. Enhanced antitumor activity of a combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model
14. Targeting of LAK activity to CEA-expressing tumor cells with an anti-CEA scFv/IL-2 fusion protein
15. Engineering hybrid genes without the use of restriction enzymes: Gene splicing by overlap extension
16. In vivo tumor targeting of a recombinant single-chain antigen-binding protein
17. Homotypic and heterotypic Ca++-independent cell adhesion activities of biliary glycoprotein, a member of carcinoembryonic antigen family, expressed on CHO cell surface
18. Effective adoptive immunotherapy by T-LAK cells retargeted with bacterial superantigen-conjugated antibody to MUC1 in xenografted severe combined immunodeficient mice
19. Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese hamster ovary cells and 25 distinct monoclonal antibodies
20. SEA-scFv as a bifunctional antibody: Construction of a bacterial expression system and its functional analysis
21. Monoclonal antibody-superantigen fusion proteins: Tumor-specific agents for T-cell-based tumor therapy
22. Treatment with tumor-reactive Fab-IL-2 and Fab-staphylococcal enterotoxin A fusion proteins leads to sustained T cell activation, and long-term survival of mice with established tumors
23. Nucleotide sequence of the type A staphylococcal enterotoxin gene
24. The staphylococcal enterotoxins and their relatives
25. MHC class II-independent Vb-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: Implications for use in treatment of human colon carcinoma
26. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
27. Human antibody engineering
28. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli
29. Single-chain antigen-binding proteins
30. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
31. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms
32. Improved tumor targeting with chemically cross-linked recombinant antibody fragments